Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis.

European heart journal·2026
Same author

Managing a Pregnant Patient With a Mechanical Heart Valve and Subchorionic Hematomas.

JACC. Case reports·2026
Same author

Second Wave: Dynamic LVOT Obstruction in a Patient With Previous Subaortic Membrane.

Circulation. Heart failure·2026
Same author

The association of inflammatory response with speckled global strain in recovered patients with myocarditis.

Annals of medicine and surgery (2012)·2026
Same author

Peripartum Cardiomyopathy: Lessons From Long-Term Outcomes in Israel.

JACC. Heart failure·2025
Same author

Troponin at presentation: A key predictor of chronic myocardial impairment post-myocarditis-A prospective cohort study.

JRSM cardiovascular disease·2025
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

Related Experiment Videos

Anticoagulation in pregnancy.

Sorel Goland1, Uri Elkayam

  • 1Department of Cardiology, Kaplan Medical Center, PO Box 1, Rehovot, Israel 76100. sorelgoland@yahoo.com

Cardiology Clinics
|July 21, 2012
PubMed
Summary
This summary is machine-generated.

Pregnancy-associated thrombosis requires careful anticoagulation management. This review focuses on anticoagulation for pregnant women with mechanical heart valves, addressing challenges in optimal antithrombotic therapy.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Obstetrics
  • Hematology

Background:

  • Pregnancy-associated thrombosis is a significant cause of maternal morbidity and mortality.
  • Anticoagulation is crucial for managing thrombotic complications but carries risks.
  • Managing pregnant women with mechanical heart valves lacks definitive clinical trial guidelines.

Purpose of the Study:

  • To review anticoagulation therapy during pregnancy for thromboembolic prophylaxis.
  • To focus on the specific challenges in managing pregnant patients with mechanical heart valves.

Main Methods:

  • Literature review of anticoagulation strategies in pregnancy.
  • Analysis of existing evidence for thromboembolic prophylaxis.
  • Focus on cardiovascular disorders, particularly mechanical heart valves.

Main Results:

  • Anticoagulation therapy is essential but complex in pregnancy.
  • Mechanical heart valve management in pregnant patients remains a clinical challenge.
  • Lack of controlled trials necessitates careful consideration of available data.

Conclusions:

  • Optimal antithrombotic therapy for pregnant women with mechanical valves requires further research.
  • This review synthesizes current information to guide clinical practice.
  • Evidence-based recommendations are needed for this high-risk population.